SSC Releases Updated Statement in Response to ProCESS and ARISE Trials

The Surviving Sepsis Campaign (SSC) released an updated statement regarding hemodynamic and oximetric monitoring. The statement is in response to the Protocolized Care for Early Septic Shock (ProCESS) and the Australasian Resuscitation in Sepsis Evaluation (ARISE) trials.

The statement highlights recently released data from the Surviving Sepsis Campaign, which confirms that “adherence to quality improvement measures in severe sepsis and septic shock is associated with mortality decline.” The research has been published online ahead of print in Critical Care Medicine and in Intensive Care Medicine. The final print version is scheduled to appear in the January 2015 edition of Critical Care Medicine.

eNewsletter Issue: